What changed in APOGEE ENTERPRISES, INC.'s 10-K — 2023 vs 2024
Paragraph-level year-over-year comparison of APOGEE ENTERPRISES, INC.'s 2023 and 2024 10-K annual filings, covering the Business, Risk Factors, Legal Proceedings, Cybersecurity, MD&A and Market Risk sections. Every new, removed and edited paragraph is highlighted side-by-side so you can see exactly what management changed in the 2024 report.
Top changes in APOGEE ENTERPRISES, INC.'s 2024 10-K
267 paragraphs added · 268 removed · 165 edited across 7 sections
- Item 7. Management's Discussion & Analysis+99 / −115 · 44 edited
- Item 1A. Risk Factors+74 / −61 · 42 edited
- Item 1. Business+74 / −73 · 63 edited
- Item 5. Market for Registrant's Common Equity+7 / −6 · 4 edited
- Item 7A. Quantitative and Qualitative Disclosures About Market Risk+8 / −8 · 7 edited
Item 1. Business
Business — how the company describes what it does
63 edited+11 added−10 removed13 unchanged
Item 1. Business
Business — how the company describes what it does
… 4 more changes not shown on this page.
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
42 edited+32 added−19 removed16 unchanged
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
… 13 more changes not shown on this page.
Item 2. Properties
Properties — owned and leased real estate
2 edited+0 added−0 removed0 unchanged
Item 2. Properties
Properties — owned and leased real estate
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
3 edited+0 added−0 removed2 unchanged
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
4 edited+3 added−2 removed2 unchanged
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
44 edited+55 added−71 removed32 unchanged
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
… 90 more changes not shown on this page.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure
7 edited+1 added−1 removed7 unchanged
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure